Ampio Pharmaceuticals Issues Letter To Stockholders
Ampio Pharmaceuticals Issues Letter To Stockholders
Ampio制药公司向股东发出信函
Ampio Pharmaceuticals, Inc. (NYSE:AMPE), today released the following letter to stockholders from its Chairman, Kevin Buchi, and Chief Executive Officer, Mike Martino.
亚洲网加利福尼亚州圣何塞10月24日电安皮奥制药公司(纽约证券交易所市场代码：AMPE)今天发布了其董事长凯文·布奇和首席执行官Mike·马蒂诺致股东的以下信件。
Dear Fellow Ampio Stockholder,
亲爱的Ampio股东朋友，
On behalf of the Board of Directors, we are reaching out to you directly to ask you to vote "FOR" the proposal to authorize a reverse stock-split in advance of the Ampio Special Stockholder meeting on October 13, 2022.
我们代表董事会直接与您联系，请您在2022年10月13日Ampio特别股东大会之前投票支持授权反向股票拆分的提议。
As many of you are aware, the NYSE Regulation has determined that the Company is no longer suitable for listing on the NYSE American Exchange ("Exchange") due to the abnormally low trading price of its...
正如你们许多人所知，纽约证券交易所的法规已经确定，由于其普通股的交易价...
登录免费看全文
登录/注册